| Literature DB >> 16825927 |
Abstract
Inflammatory bowel diseases are associated with extraintestinal manifestations involving almost every organ system in the body. They occur in approximately 20% to 40% of patients with inflammatory bowel diseases. Immune-related and genetic mechanisms play an important role in the pathogenesis of these complications. Peripheral arthritis, erythema nodosum, and episcleritis respond to the treatment of the underlying intestinal inflammation, whereas axial arthropathy, pyoderma gangrenosum, and uveitis do not. Immunomodulator therapy, particularly with biologic agents has been shown to be effective in treating some of the extraintestinal manifestations. Early recognition and treatment are crucial in preventing major morbidity.Entities:
Mesh:
Year: 2006 PMID: 16825927 DOI: 10.1097/00004836-200607000-00003
Source DB: PubMed Journal: J Clin Gastroenterol ISSN: 0192-0790 Impact factor: 3.062